clear eyes redness relief
Generic: naphazoline hydrochloride and glycerin
Labeler: prestige brands holdings, inc.Drug Facts
Product Profile
Brand Name
clear eyes redness relief
Generic Name
naphazoline hydrochloride and glycerin
Labeler
prestige brands holdings, inc.
Dosage Form
LIQUID
Routes
Active Ingredients
glycerin 2.5 mg/mL, naphazoline hydrochloride .12 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
67172-797
Product ID
67172-797_7ac3f311-3e91-4c87-9cbe-fc632c5ba546
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M018
Listing Expiration
2026-12-31
Marketing Start
2011-04-27
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67172797
Hyphenated Format
67172-797
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
clear eyes redness relief (source: ndc)
Generic Name
naphazoline hydrochloride and glycerin (source: ndc)
Application Number
M018 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2.5 mg/mL
- .12 mg/mL
Packaging
- 1 BOTTLE in 1 BOX (67172-797-01) / 30 mL in 1 BOTTLE
- 1 BOTTLE, DROPPER in 1 CARTON (67172-797-06) / 6 mL in 1 BOTTLE, DROPPER
- 1 BOTTLE, DROPPER in 1 CARTON (67172-797-15) / 15 mL in 1 BOTTLE, DROPPER
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "7ac3f311-3e91-4c87-9cbe-fc632c5ba546", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "unii": ["PDC6A3C0OX", "MZ1131787D"], "rxcui": ["1046700"], "spl_set_id": ["a26ef66e-2def-4c98-9959-d40d4cfe3108"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Prestige Brands Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOX (67172-797-01) / 30 mL in 1 BOTTLE", "package_ndc": "67172-797-01", "marketing_start_date": "20110427"}, {"sample": false, "description": "1 BOTTLE, DROPPER in 1 CARTON (67172-797-06) / 6 mL in 1 BOTTLE, DROPPER", "package_ndc": "67172-797-06", "marketing_start_date": "20110427"}, {"sample": false, "description": "1 BOTTLE, DROPPER in 1 CARTON (67172-797-15) / 15 mL in 1 BOTTLE, DROPPER", "package_ndc": "67172-797-15", "marketing_start_date": "20110427"}], "brand_name": "Clear Eyes Redness Relief", "product_id": "67172-797_7ac3f311-3e91-4c87-9cbe-fc632c5ba546", "dosage_form": "LIQUID", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Non-Standardized Chemical Allergen [EPC]"], "product_ndc": "67172-797", "generic_name": "Naphazoline Hydrochloride and Glycerin", "labeler_name": "Prestige Brands Holdings, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Clear Eyes Redness Relief", "active_ingredients": [{"name": "GLYCERIN", "strength": "2.5 mg/mL"}, {"name": "NAPHAZOLINE HYDROCHLORIDE", "strength": ".12 mg/mL"}], "application_number": "M018", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20110427", "listing_expiration_date": "20261231"}